CY1119731T1 - Διαδικασια για την παρασκευη παραγωγων χολικου οξεος - Google Patents

Διαδικασια για την παρασκευη παραγωγων χολικου οξεος

Info

Publication number
CY1119731T1
CY1119731T1 CY20181100003T CY181100003T CY1119731T1 CY 1119731 T1 CY1119731 T1 CY 1119731T1 CY 20181100003 T CY20181100003 T CY 20181100003T CY 181100003 T CY181100003 T CY 181100003T CY 1119731 T1 CY1119731 T1 CY 1119731T1
Authority
CY
Cyprus
Prior art keywords
bital
procedure
production
acid producers
producers
Prior art date
Application number
CY20181100003T
Other languages
Greek (el)
English (en)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Original Assignee
Intercept Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals, Inc. filed Critical Intercept Pharmaceuticals, Inc.
Publication of CY1119731T1 publication Critical patent/CY1119731T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20181100003T 2012-10-26 2018-01-03 Διαδικασια για την παρασκευη παραγωγων χολικου οξεος CY1119731T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CY1119731T1 true CY1119731T1 (el) 2018-06-27

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100003T CY1119731T1 (el) 2012-10-26 2018-01-03 Διαδικασια για την παρασκευη παραγωγων χολικου οξεος

Country Status (22)

Country Link
US (2) US9777038B2 (enExample)
EP (1) EP2912013B1 (enExample)
JP (1) JP6272888B2 (enExample)
KR (1) KR102068381B1 (enExample)
CN (2) CN105102425B (enExample)
AU (1) AU2013334122B2 (enExample)
BR (1) BR112015009395A2 (enExample)
CA (1) CA2889592A1 (enExample)
CY (1) CY1119731T1 (enExample)
DK (1) DK2912013T3 (enExample)
ES (1) ES2655034T3 (enExample)
HK (1) HK1253301A1 (enExample)
HU (1) HUE036887T2 (enExample)
IL (1) IL238454B (enExample)
MX (1) MX361653B (enExample)
NO (1) NO2968302T3 (enExample)
NZ (2) NZ745013A (enExample)
PL (1) PL2912013T3 (enExample)
PT (1) PT2912013T (enExample)
SG (1) SG11201503247UA (enExample)
SM (1) SMT201700602T1 (enExample)
WO (1) WO2014066819A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives
PT3149019T (pt) 2014-05-29 2020-02-19 Bar Pharmaceuticals S R L Derivados de colano para utilização no tratamento e/ou na prevenção de doenças mediadas por fxr e tgr5/gp-bar1
ES2748692T3 (es) 2014-11-19 2020-03-17 Nzp Uk Ltd Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la producción de moduladores FXR de esteroides
EA033427B1 (ru) 2014-11-19 2019-10-31 Nzp Uk Ltd 6-алкил-7-гидрокси-4-ен-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
PL3221332T3 (pl) 2014-11-19 2019-10-31 Nzp Uk Ltd Steroidy, 5.beta.-6-alkilo-7-hydroksy-3-ony jako związki pośrednie do wytwarzania steroidowych modulatorów fxr
KR102527821B1 (ko) 2014-11-19 2023-05-02 엔제트피 유케이 리미티드 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-6,7-다이온 스테로이드
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
BR112017016766B1 (pt) 2015-02-06 2023-11-07 Intercept Pharmaceuticals, Inc Composição compreendendo um agonista fxr e fibrato, bem como uso para tratar doença hepática colestática
CN108350020A (zh) 2015-09-24 2018-07-31 英特塞普特医药品公司 用于制备胆汁酸衍生物的方法和中间体
EP3370728A4 (en) * 2015-11-06 2019-07-10 Intercept Pharmaceuticals, Inc. PROCESS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
WO2017142895A1 (en) * 2016-02-15 2017-08-24 Regents Of The University Of Minnesota Compositions and methods for treating clostridium associated diseases
KR102377338B1 (ko) 2016-04-13 2022-03-21 인터셉트 파마슈티컬즈, 인크. 암의 치료 방법
TW201738254A (zh) 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
MX2019003684A (es) * 2016-09-30 2019-08-05 Intercept Pharmaceuticals Inc Formas cristalinas de un derivado de acido biliar.
MX2020000873A (es) * 2017-07-24 2020-07-22 Intercept Pharmaceuticals Inc Derivados de ácidos biliares marcados isotópicamente.
CN110869381B (zh) * 2017-07-26 2021-11-19 正大天晴药业集团股份有限公司 甾体类衍生物fxr激动剂的制备方法
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
JP2022536060A (ja) 2019-05-30 2022-08-12 インターセプト ファーマシューティカルズ, インコーポレイテッド 胆汁鬱滞性肝疾患の処置で使用するためのfxrアゴニストおよびフィブラートを含む医薬組成物
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
JP7745559B2 (ja) 2020-02-28 2025-09-29 キャリーオペ,インク. Gpr40アゴニスト
BR112022023359A2 (pt) 2020-05-19 2023-04-18 Kallyope Inc Ativadores de ampk
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ,インク. Ampkアクチベーター
WO2022059948A1 (ko) 2020-09-18 2022-03-24 서울대학교 산학협력단 소디움 타우로디옥시콜레이트의 대량 생산 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
EP1392714B1 (en) 2001-03-12 2005-08-31 Intercept Pharmaceuticals, Inc. Steroids as agonists for fxr
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
CA2656320C (en) * 2006-06-27 2015-04-28 Intercept Pharmaceuticals, Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
CA2732323C (en) * 2008-07-30 2017-06-27 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
EP2373673B1 (en) * 2008-11-19 2016-07-27 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
CN105102425B (zh) 2018-04-10
WO2014066819A1 (en) 2014-05-01
AU2013334122B2 (en) 2017-11-02
KR20150074062A (ko) 2015-07-01
JP6272888B2 (ja) 2018-01-31
BR112015009395A2 (pt) 2017-07-04
CN105102425A (zh) 2015-11-25
US10202414B2 (en) 2019-02-12
JP2015533852A (ja) 2015-11-26
ES2655034T3 (es) 2018-02-16
SG11201503247UA (en) 2015-06-29
MX2015005286A (es) 2015-10-29
US20150291653A1 (en) 2015-10-15
US9777038B2 (en) 2017-10-03
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
IL238454A0 (en) 2015-06-30
DK2912013T3 (en) 2018-01-15
EP2912013B1 (en) 2017-10-11
EP2912013A4 (en) 2016-06-01
US20180079776A1 (en) 2018-03-22
NO2968302T3 (enExample) 2018-02-03
SMT201700602T1 (it) 2018-03-08
PT2912013T (pt) 2018-01-03
KR102068381B1 (ko) 2020-01-20
AU2013334122A1 (en) 2015-05-14
NZ707389A (en) 2018-08-31
MX361653B (es) 2018-12-13
CN108250264A (zh) 2018-07-06
EP2912013A1 (en) 2015-09-02
HK1253301A1 (zh) 2019-06-14
NZ745013A (en) 2019-08-30
IL238454B (en) 2018-11-29
CA2889592A1 (en) 2014-05-01
PL2912013T3 (pl) 2018-05-30

Similar Documents

Publication Publication Date Title
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CY1119422T1 (el) Παραγωγα μπετουλινης
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
CY1118478T1 (el) Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου
UY35683A (es) Polimorfo de inhibidores de tirosina quinasa de bazo (syk)
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
MX390726B (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen tales compuestos.
EA201590319A1 (ru) Новые бициклические пиридиноны
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
CR20150271A (es) Peptidos como agonistas de oxitocina
CO6821935A2 (es) Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
CR20150087A (es) Derivados de pirazol-carboxamida
EA201200123A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
EA201690908A1 (ru) Пиразолопиримидиновые соединения
EA201201385A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
IN2013MU01355A (enExample)
IN2014DN07498A (enExample)